Complete Filing Data
Atea Pharmaceuticals, Inc. reported Stockholders Equity of $275.43 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Atea Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$158.3M | -$168.4M | -$136.0M | -$115.9M | $121.2M | -$10.9M | -$14.0M | -$9.1M |
| Research And Development Expense | $148.0M | $144.1M | $114.2M | $81.9M | $167.2M | $38.0M | $10.2M | $6.7M |
| Operating Income Loss | -$180.9M | -$193.0M | -$164.2M | -$130.7M | $138.4M | -$11.0M | -$14.6M | -$9.5M |
| Operating Expenses | $180.9M | $193.0M | $164.2M | $130.7M | $213.0M | $59.7M | $14.6M | $9.5M |
| General And Administrative Expense | $32.9M | $48.8M | $49.9M | $48.7M | $45.8M | $21.6M | $4.4M | $2.8M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$164.5M | -$167.5M | -$134.9M | -$119.5M | $138.6M | -$10.9M | -$14.0M | |
| Income Tax Expense Benefit | -$6.2M | $925.0K | $1.0M | -$3.6M | $17.4M | |||
| Comprehensive Income Net Of Tax | -$158.4M | -$168.4M | -$135.1M | -$116.6M | $121.2M | -$10.9M | ||
| Other Comprehensive Income Loss Net Of Tax | -$59.0K | $26.0K | $891.0K | -$684.0K | ||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$59.0K | $26.0K | $891.0K | -$684.0K | ||||
| Accrued Income Taxes Noncurrent | $0.00 | $6.4M | $5.8M | $5.3M | $5.9M | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $351.4M | $48.6M | ||||||
| Deferred Revenue Current | $301.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$42.0M | -$37.2M | -$34.3M | -$31.2M | -$40.5M | -$63.2M | -$33.1M | -$28.2M | -$35.5M | -$8.1M | -$31.3M | -$42.1M | -$28.2M | $1.5M | $30.7M | -$17.6M | -$10.0M | -$4.0M | -$3.6M | -$3.6M | -$2.2M |
| Research And Development Expense | $38.3M | $32.3M | $29.6M | $26.2M | $34.7M | $57.6M | $28.2M | $22.1M | $29.0M | $4.9M | $19.9M | $29.6M | $43.0M | $39.8M | $26.6M | $13.6M | $7.8M | $2.8M | $2.4M | ||
| Operating Income Loss | -$45.6M | -$41.3M | -$39.0M | -$37.2M | -$46.9M | -$69.8M | -$40.8M | -$35.2M | -$41.6M | -$16.3M | -$32.3M | -$42.2M | -$22.1M | $8.7M | $30.7M | -$17.6M | -$10.0M | -$4.0M | -$3.8M | ||
| Operating Expenses | $45.6M | $41.3M | $39.0M | $37.2M | $46.9M | $69.8M | $40.8M | $35.2M | $41.6M | $16.3M | $32.3M | $42.2M | $55.0M | $51.7M | $35.3M | $17.6M | $10.0M | $4.0M | $3.8M | ||
| General And Administrative Expense | $7.2M | $9.1M | $9.5M | $11.0M | $12.2M | $12.2M | $12.6M | $13.2M | $12.6M | $11.4M | $12.4M | $12.5M | $11.9M | $11.9M | $8.8M | $4.0M | $2.2M | $1.2M | $1.4M | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$41.9M | -$37.0M | -$34.1M | -$30.9M | -$40.3M | -$62.9M | -$32.9M | -$27.9M | -$35.3M | -$11.9M | -$31.2M | -$42.1M | -$22.1M | $8.7M | $30.7M | -$17.6M | -$10.0M | ||||
| Income Tax Expense Benefit | $196.0K | $207.0K | $203.0K | $226.0K | $243.0K | $231.0K | $221.0K | $251.0K | $197.0K | -$3.8M | $120.0K | $0.00 | $6.1M | $7.2M | |||||||
| Comprehensive Income Net Of Tax | -$41.8M | -$37.2M | -$34.4M | -$30.2M | -$40.6M | -$63.6M | -$33.1M | -$28.2M | -$35.1M | -$8.9M | -$31.3M | -$42.1M | -$28.2M | ||||||||
| Other Comprehensive Income Loss Net Of Tax | $201.0K | -$81.0K | -$115.0K | $921.0K | -$99.0K | -$388.0K | $48.0K | -$3.0K | $377.0K | -$855.0K | |||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $201.0K | -$81.0K | -$115.0K | $921.0K | -$99.0K | -$388.0K | $48.0K | -$3.0K | $377.0K | -$855.0K | |||||||||||
| Accrued Income Taxes Noncurrent | $6.8M | $6.6M | $6.5M | $6.2M | $6.1M | $5.9M | $5.6M | $5.5M | $5.4M | $5.2M | $6.0M | $5.9M | |||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $32.8M | $60.4M | $66.0M | ||||||||||||||||||
| Deferred Revenue Current | $192.2M | $225.0M | $235.4M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $275.4M | $438.9M | $555.2M | $640.6M | $710.1M | $547.8M | -$49.6M | -$36.2M | -$27.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $95.7M | $64.7M | $143.8M | $188.7M | $764.7M | $850.2M | $21.8M | $34.6M | $15.0M |
| Cash And Cash Equivalents At Carrying Value | $95.7M | $64.7M | $143.8M | $188.5M | $764.4M | $850.1M | $21.7M | $34.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $31.0M | -$79.1M | -$44.8M | -$576.0M | -$85.5M | $828.5M | -$12.8M | $19.6M | |
| Retained Earnings Accumulated Deficit | -$522.6M | -$364.2M | -$195.8M | -$59.9M | $56.0M | -$65.2M | -$54.2M | ||
| Property Plant And Equipment Net | $457.0K | $873.0K | $1.3M | $1.7M | $23.0K | $48.0K | $41.0K | ||
| Prepaid Expense And Other Assets Current | $9.2M | $7.6M | $12.3M | $14.2M | $8.0M | $7.5M | $249.0K | ||
| Liabilities Current | $39.8M | $18.6M | $32.4M | $18.5M | $56.9M | $315.8M | $2.4M | ||
| Liabilities And Stockholders Equity | $315.2M | $464.7M | $595.0M | $666.7M | $772.9M | $863.6M | $22.1M | ||
| Liabilities | $39.8M | $25.8M | $39.8M | $26.1M | $62.8M | $315.8M | $2.5M | ||
| Common Stock Value | $78.0K | $84.0K | $83.0K | $83.0K | $83.0K | $82.0K | $10.0K | ||
| Assets Current | $311.0M | $462.4M | $590.5M | $660.9M | $772.4M | $863.5M | $21.9M | ||
| Assets | $315.2M | $464.7M | $595.0M | $666.7M | $772.9M | $863.6M | $22.1M | ||
| Accrued Liabilities And Other Liabilities | $26.0M | $13.3M | $27.4M | $15.2M | $52.2M | $14.4M | $1.9M | ||
| Accounts Payable Current | $12.9M | $4.5M | $4.3M | $2.6M | $4.5M | $60.0K | $548.0K | ||
| Other Assets Noncurrent | $3.1M | $197.0K | $1.4M | $1.5M | $466.0K | $107.0K | $122.0K | ||
| Operating Lease Right Of Use Asset | $634.0K | $1.2M | $1.8M | $2.4M | $161.0K | ||||
| Operating Lease Liability Current | $843.0K | $800.0K | $760.0K | $721.0K | $197.0K | ||||
| Restricted Cash | $198.0K | $305.0K | $107.0K | $107.0K | $107.0K | ||||
| Operating Lease Liability Noncurrent | $0.00 | $842.0K | $1.6M | $2.4M | |||||
| Available For Sale Securities Debt Securities Current | $206.1M | $390.0M | $434.3M | $458.2M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $174.0K | $233.0K | $207.0K | -$684.0K | |||||
| Accretion Amortization Of Discounts And Premiums Investments | $4.9M | $11.8M | $15.4M | $5.5M | |||||
| Restricted Cash Noncurrent | $198.0K | $305.0K | |||||||
| Other Liabilities Noncurrent | $5.9M | $36.0K | $95.0K | ||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $2.9M | ||||||||
| Amortization Of Debt Discount Premium | -$5.5M | ||||||||
| Unbilled Receivables Current | $5.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $315.8M | $364.4M | $411.1M | $458.5M | $476.5M | $504.4M | $581.7M | $602.3M | $618.2M | $663.2M | $660.5M | $679.9M | $581.5M | $597.9M | $586.3M | -$76.5M | -$63.1M | -$53.4M | -$45.1M | -$41.6M | -$38.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $77.3M | $87.7M | $119.4M | $98.5M | $243.4M | $160.9M | $137.9M | $213.9M | $183.5M | $176.7M | $684.8M | $705.9M | $840.0M | $816.6M | $833.9M | $105.5M | $115.9M | $17.3M | $25.7M | ||
| Cash And Cash Equivalents At Carrying Value | $77.3M | $87.7M | $119.4M | $98.5M | $243.4M | $160.9M | $137.9M | $213.7M | $183.3M | $176.4M | $684.5M | $705.5M | $839.7M | $816.5M | $833.8M | $105.4M | $115.8M | $17.1M | $25.6M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $54.7M | $17.1M | -$5.2M | -$58.8M | -$16.4M | -$4.5M | |||||||||||||||
| Retained Earnings Accumulated Deficit | -$477.7M | -$435.7M | -$398.5M | -$330.7M | -$299.5M | -$259.0M | -$156.7M | -$123.5M | -$95.3M | -$25.4M | -$17.4M | $14.0M | -$61.1M | -$32.9M | -$34.4M | -$85.8M | |||||
| Property Plant And Equipment Net | $561.0K | $665.0K | $769.0K | $977.0K | $1.1M | $1.2M | $1.4M | $1.5M | $1.6M | $1.8M | $1.9M | $762.0K | $26.0K | $33.0K | $41.0K | $49.0K | |||||
| Prepaid Expense And Other Assets Current | $6.8M | $5.9M | $8.3M | $4.1M | $4.2M | $7.3M | $8.2M | $12.8M | $11.9M | $12.4M | $5.0M | $7.7M | $3.3M | $4.7M | $6.4M | $3.0M | |||||
| Liabilities Current | $20.2M | $20.1M | $21.7M | $25.2M | $26.6M | $41.3M | $18.9M | $16.2M | $12.4M | $15.6M | $25.1M | $28.6M | $262.1M | $273.7M | $254.3M | $10.8M | |||||
| Liabilities And Stockholders Equity | $343.0M | $391.6M | $440.0M | $491.0M | $510.4M | $553.0M | $608.1M | $626.0M | $638.1M | $686.6M | $694.3M | $717.2M | $843.5M | $871.5M | $840.6M | $110.1M | |||||
| Liabilities | $27.2M | $27.2M | $28.9M | $32.4M | $33.9M | $48.7M | $26.3M | $23.7M | $19.9M | $23.4M | $33.9M | $37.3M | $262.1M | $273.7M | $254.4M | $10.9M | |||||
| Common Stock Value | $78.0K | $81.0K | $85.0K | $84.0K | $84.0K | $84.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $10.0K | |||||
| Assets Current | $336.1M | $385.6M | $433.7M | $486.9M | $506.4M | $548.8M | $603.3M | $620.8M | $632.4M | $681.9M | $689.5M | $713.2M | $842.9M | $871.1M | $840.1M | $108.4M | |||||
| Assets | $343.0M | $391.6M | $440.0M | $491.0M | $510.4M | $553.0M | $608.1M | $626.0M | $638.1M | $686.6M | $694.3M | $717.2M | $843.5M | $871.5M | $840.6M | $110.1M | |||||
| Accrued Liabilities And Other Liabilities | $15.8M | $10.5M | $13.5M | $18.6M | $20.4M | $19.4M | $17.7M | $11.5M | $10.9M | $13.8M | $10.5M | $24.8M | $47.7M | $38.0M | $15.1M | $6.3M | |||||
| Accounts Payable Current | $3.5M | $8.8M | $7.4M | $5.8M | $5.5M | $21.1M | $395.0K | $4.0M | $700.0K | $1.1M | $13.9M | $3.7M | $22.2M | $10.7M | $3.8M | $4.5M | |||||
| Other Assets Noncurrent | $5.5M | $4.4M | $4.4M | $1.7M | $1.4M | $1.4M | $1.4M | $1.4M | $1.7M | $532.0K | $400.0K | $463.0K | $1.6M | ||||||||
| Operating Lease Right Of Use Asset | $789.0K | $942.0K | $1.1M | $1.4M | $1.5M | $1.7M | $2.0M | $2.1M | $2.3M | $2.5M | $2.7M | $2.9M | |||||||||
| Operating Lease Liability Current | $832.0K | $821.0K | $811.0K | $790.0K | $780.0K | $769.0K | $750.0K | $740.0K | $730.0K | $711.0K | $730.0K | $113.0K | |||||||||
| Restricted Cash | $198.0K | $198.0K | $305.0K | $305.0K | $305.0K | $305.0K | $107.0K | $107.0K | $107.0K | $107.0K | $107.0K | $107.0K | |||||||||
| Operating Lease Liability Noncurrent | $213.0K | $425.0K | $634.0K | $1.0M | $1.2M | $1.4M | $1.8M | $2.0M | $2.2M | $2.6M | $2.8M | $2.8M | |||||||||
| Available For Sale Securities Debt Securities Current | $252.0M | $292.0M | $306.0M | $384.4M | $258.8M | $380.6M | $457.2M | $394.4M | $437.2M | $488.6M | |||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $238.0K | $37.0K | $118.0K | $641.0K | -$280.0K | -$181.0K | -$262.0K | -$310.0K | -$307.0K | -$855.0K | |||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.7M | $3.5M | $3.1M | ||||||||||||||||||
| Restricted Cash Noncurrent | $198.0K | $198.0K | $305.0K | $305.0K | $305.0K | ||||||||||||||||
| Other Liabilities Noncurrent | $29.0K | $113.0K | $56.0K | ||||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $2.9M | ||||||||||||||||||||
| Amortization Of Debt Discount Premium | -$3.1M | ||||||||||||||||||||
| Unbilled Receivables Current |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $20.7M | $51.8M | $49.4M | $46.7M | $39.6M | $7.5M | $624.0K | $414.0K |
| Net Cash Provided By Used In Operating Activities | -$132.0M | -$135.5M | -$85.4M | -$121.0M | -$87.0M | $296.7M | -$12.8M | -$7.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.5M | -$5.9M | -$1.9M | $6.3M | $483.0K | $7.3M | $43.0K | -$86.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $12.7M | -$13.4M | $12.7M | -$37.6M | $43.9M | $12.4M | $450.0K | $729.0K |
| Increase Decrease In Accounts Payable | $8.5M | $206.0K | $1.7M | -$2.0M | $10.3M | -$488.0K | $157.0K | -$90.0K |
| Net Cash Provided By Used In Financing Activities | -$25.7M | $267.0K | $257.0K | $370.0K | $1.5M | $531.7M | $27.5M | |
| Net Cash Provided By Used In Investing Activities | $188.8M | $56.1M | $40.3M | -$455.4M | -$4.0K | -$26.0K | -$2.0K | -$12.0K |
| Increase Decrease In Other Operating Assets | $2.9M | $0.00 | -$98.0K | $1.5M | $161.0K | $0.00 | ||
| Increase Decrease In Operating Lease Liability | -$190.0K | -$175.0K | -$161.0K | $765.0K | ||||
| Proceeds From Stock Plans | $201.0K | $267.0K | $257.0K | $140.0K | ||||
| Payments To Acquire Available For Sale Securities Debt | $281.9M | $461.2M | $562.4M | $545.4M | ||||
| Proceeds From Sale And Maturity Of Marketable Securities | $470.7M | $517.3M | $602.7M | $91.9M | ||||
| Proceeds From Stock Options Exercised | $58.0K | $0.00 | $230.0K | $1.5M | $27.0K | |||
| Payments To Acquire Property Plant And Equipment | $1.9M | $4.0K | $26.0K | $2.0K | $12.0K | |||
| Increase Decrease In Contract With Customer Liability | -$301.4M | $301.4M | ||||||
| Proceeds From Issuance Of Convertible Preferred Stock | $214.1M | $27.4M | ||||||
| Payments Related To Tax Withholding For Share Based Compensation | $485.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $7.0M | $12.6M | $12.5M | $11.7M | $7.3M | $189.0K |
| Net Cash Provided By Used In Operating Activities | -$30.6M | -$39.9M | -$29.9M | -$59.0M | -$16.8M | -$4.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $638.0K | -$5.1M | -$2.3M | -$275.0K | -$1.2M | $192.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $347.0K | -$7.8M | -$4.2M | -$28.0M | $6.6M | -$371.0K |
| Increase Decrease In Accounts Payable | $2.9M | $16.9M | -$1.9M | -$877.0K | $3.7M | -$150.0K |
| Net Cash Provided By Used In Financing Activities | -$347.0K | $150.0K | $165.0K | $223.0K | $471.0K | -$6.0K |
| Net Cash Provided By Used In Investing Activities | $85.6M | $56.8M | $24.5M | -$44.0K | ||
| Increase Decrease In Other Operating Assets | $4.2M | $197.0K | $356.0K | |||
| Increase Decrease In Operating Lease Liability | -$47.0K | -$44.0K | -$41.0K | |||
| Proceeds From Stock Plans | $138.0K | $150.0K | $165.0K | |||
| Payments To Acquire Available For Sale Securities Debt | $122.6M | $167.2M | $156.6M | |||
| Proceeds From Sale And Maturity Of Marketable Securities | $208.2M | $224.0M | $181.1M | |||
| Proceeds From Stock Options Exercised | $223.0K | $471.0K | ||||
| Payments To Acquire Property Plant And Equipment | $44.0K | |||||
| Increase Decrease In Contract With Customer Liability | -$66.0M | |||||
| Proceeds From Issuance Of Convertible Preferred Stock | ||||||
| Payments Related To Tax Withholding For Share Based Compensation | $485.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.94 | -$2.00 | -$1.63 | -$1.39 | $1.37 | -$0.51 | -$1.39 | -$0.90 |
| Weighted Average Number Of Shares Outstanding Basic | 81.5M | 84.3M | 83.4M | 83.2M | 82.8M | 21.6M | 10.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 81.5M | 84.3M | 83.4M | 83.2M | 88.2M | 21.6M | 10.1M | |
| Earnings Per Share Basic | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.46 | $-0.51 | $-1.39 | |
| Common Stock Shares Outstanding | 78.1M | 84.5M | 83.4M | 83.3M | 83.1M | 82.4M | 10.1M | |
| Common Stock Shares Issued | 78.1M | 84.5M | 83.4M | 83.3M | 83.1M | 82.4M | 10.1M | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 53.1M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 21.6M | 10.1M | 10.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.53 | -$0.44 | -$0.40 | -$0.37 | -$0.48 | -$0.75 | -$0.40 | -$0.34 | -$0.43 | -$0.10 | -$0.38 | -$0.51 | -$0.34 | $0.02 | $0.34 | -$1.74 | -$0.99 | -$0.40 | -$0.36 |
| Weighted Average Number Of Shares Outstanding Basic | 79.1M | 83.7M | 85.2M | 84.4M | 84.3M | 83.9M | 83.4M | 83.4M | 83.3M | 83.3M | 83.3M | 83.2M | 82.8M | 82.7M | 82.6M | 10.1M | 10.1M | 10.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 79.1M | 83.7M | 85.2M | 84.4M | 84.3M | 83.9M | 83.4M | 83.4M | 83.3M | 83.3M | 83.3M | 83.2M | 82.8M | 88.1M | 89.1M | 10.1M | 10.1M | 10.1M | |
| Earnings Per Share Basic | $-0.53 | $-0.44 | $-0.40 | $-0.37 | $-0.48 | $-0.75 | $-0.40 | $-0.34 | $-0.43 | $-0.10 | $-0.38 | $-0.51 | $-0.34 | $0.02 | $0.37 | $-1.74 | $-0.99 | $-0.40 | |
| Common Stock Shares Outstanding | 78.1M | 81.1M | 85.6M | 84.5M | 84.4M | 84.2M | 83.4M | 83.4M | 83.4M | 83.3M | 83.3M | 83.3M | 83.0M | 82.8M | 82.7M | 10.1M | |||
| Common Stock Shares Issued | 78.1M | 81.1M | 85.6M | 84.5M | 84.4M | 84.2M | 83.4M | 83.4M | 83.4M | 83.3M | 83.3M | 83.3M | 83.0M | 82.8M | 82.7M | 10.1M | |||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 80.5M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 10.1M | 10.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $20.7M | $51.8M | $49.4M | $46.7M | $39.6M | $6.8M | $624.0K | $414.0K |
| Interest And Other Income | $16.4M | $25.5M | $29.2M | $11.2M | $213.0K | $83.0K | $574.0K | $413.0K |
| Depreciation And Amortization | $416.0K | $416.0K | $416.0K | $260.0K | $29.0K | $19.0K | $17.0K | $17.0K |
| Additional Paid In Capital | $797.8M | $802.8M | $750.7M | $701.1M | $654.0M | $612.9M | $4.6M | |
| Stock Issued During Period Value Stock Options Exercised | $58.0K | $230.0K | $1.5M | $27.0K | ||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $201.0K | $267.0K | $257.0K | $140.0K | ||||
| Stock Issued During Period Shares Stock Options Exercised | 17.4K | 155.9K | 665.8K | 18.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.5M | $4.7M | $7.0M | $12.2M | $12.7M | $12.6M | $12.4M | $12.4M | $12.5M | $11.5M | $11.9M | $11.7M | $11.0M | $10.0M | $7.3M | $4.2M | $209.0K | $189.0K | $157.0K | $147.0K | $146.0K |
| Interest And Other Income | $3.7M | $4.4M | $5.0M | $6.3M | $6.6M | $6.9M | $7.9M | $7.3M | $6.3M | $4.4M | $1.1M | $98.0K | $53.0K | $52.0K | $58.0K | $7.0K | $10.0K | $57.0K | $137.0K | ||
| Depreciation And Amortization | $104.0K | $104.0K | $104.0K | $7.0K | $7.0K | $5.0K | $4.0K | $4.0K | |||||||||||||
| Additional Paid In Capital | $793.2M | $800.0M | $809.4M | $788.5M | $776.2M | $763.5M | $738.6M | $726.1M | $713.8M | $689.4M | $677.8M | $665.8M | $642.5M | $630.7M | $620.6M | $9.3M | |||||
| Stock Issued During Period Value Stock Options Exercised | $58.0K | $7.0K | $223.0K | $795.0K | $57.0K | $471.0K | $27.0K | ||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $63.0K | $138.0K | $117.0K | $150.0K | $92.0K | $165.0K | $140.0K | ||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.